查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1850336

实验室过滤：市场份额分析、行业趋势、统计数据和成长预测（2025-2030 年）

Laboratory Filtration - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

实验室过滤市场规模预计在 2025 年达到 47 亿美元，预计到 2030 年将达到 69.1 亿美元，预测期（2025-2030 年）复合年增长率为 8.02%。

实验室过滤市场-IMG1

生物製药产量不断增长、一次性处理技术的快速普及以及先进研究工作流程中对纯度要求的日益提高，都推动了这一市场的扩张。精密级微过滤继续支持常规澄清步骤，而创新的奈米过滤平台则被用于细胞和基因治疗流程中的分子级分离。外包给契约製造组织 (CRDMO) 的增加、灵活过滤组件的普及以及永续性倡议，都在加速向无 PFAS 膜的转变。如今，竞争优势主要体现在病毒截留率、自动化相容性和数位化相容性上，这促使实验室过滤市场不断进行产品升级和平台整合。

全球实验室过滤市场趋势与洞察

生技药品生产的快速扩张

生技药品产品线正迅速扩展，涵盖单株抗体、重组蛋白、疫苗和细胞疗法。下游纯化製程需要无菌、病毒截留过滤器，能够在不损害生物分子完整性的前提下处理更高滴度的病毒。旭化成医疗（Asahi Kasei Medical）于2024年10月推出的Planova FG1过滤器，在维持病毒清除性能的同时，可将抗体处理的体积通量提高七倍。随着製造商建造灵活的工厂以实现产品快速切换，对整合式袋装一次性滤芯的强劲需求将进一步推动实验室过滤市场的发展。

基因组学和蛋白​​质组学工作流程的小型化

高通量定序和多重蛋白质体学技术已将样品用量从毫升级缩小至微升级。相容于96孔盘和384孔盘的过滤装置已成为次世代定序（NGS）文库製备和生物标记验证实验的标准配置。 Cytiva公司的Whatman Mini-UniPrep G2无针过滤器可一步完成蛋白质沉淀、颗粒去除和自动取样器管瓶集成，满足超高效液相层析法（UHPLC）的高精度需求，同时减少塑胶用量和人工操作时间。这种易于自动化的设计使实验室过滤市场能够可持续地采用数位化、无人值守的基因组学平台。

重复使用消毒级过滤器及其高成本

面临财务压力的实验室往往会重复使用昂贵的灭菌级滤膜，虽然这样可以降低高达 50% 的耗材成本，但却增加了污染和验证的风险。在规模较小的学术实验室和资源匮乏的地区，由于缺乏滤膜完整性检测基础设施，这种情况尤其严重。

细分市场分析

预计到2024年，微过滤将占全球收入的40.2%，证实了其在微生物去除和样品澄清应用中的广泛应用。然而，随着实验室采用分子级截留技术进行病毒去除、选择性盐分离和治疗级缓衝液生产，奈米过滤过滤在2030年前以每年9.6%的速度成长。杜邦公司的FilmTec LiNE-XD元件正是这一转变的例证，它在实现高锂渗透性的同时，还能有效阻隔对电池材料品管至关重要的多效价离子。

超过滤和逆渗透分别是蛋白质浓缩和超纯水生产的基础技术。将氧化石墨烯通道与聚合物骨架结合的混合膜代表了下一波跨学科突破。这些创新模糊了传统界限，迫使供应商清楚地展示与生物治疗、半导体清洗、环境测试等相关的性能指标。

区域分析

由于北美拥有先进的製药研发能力、生技产业群聚和严格的品质监管，预计到2024年，北美将占据实验室过滤市场36.4%的份额。波士顿的肯德尔广场、旧金山湾区和圣地牙哥都在建造高通量生技药品研发管线，从而确保了对灭菌级滤材、深度过滤器和一次性滤芯的稳定订单。加拿大的生技药品产能扩张计画和墨西哥具有成本竞争力的填充包装设施也进一步推动了该地区的生产。

亚太地区是最具活力的市场，预计到2030年将以10.7%的复合年增长率成长。中国各省的生命科学园区正在为待开发区工厂配备一次性过滤装置，以支持mRNA疫苗和基因编辑细胞疗法的生产。新加坡的生物医学科学计画和韩国的医药奖励策略倡议提振当地对自动化过滤设备的需求，而日本将继续以超精密膜产品占据高端市场。印度学名药生产商正在扩大其原料药过滤能，并专注于符合PIC/S协调指南且经济高效的过滤介质。

欧洲在全球实验室过滤市场占有重要地位。德国的工程技术传统推动了先进膜组件的稳定普及，而英国的细胞治疗製造生态系统则推动了针对病毒载体纯化而优化的专用过滤器设计。法国、瑞士和北欧国家正凭藉强大的分析测试能力扩大在该地区的业务。在南美洲，巴西是疫苗灌装生产线投资的中心，而中东和非洲则因国家免疫和水质计画而吸引了更多投资。

其他福利：

  • Excel格式的市场预测（ME）表
  • 3个月的分析师支持

目录

第一章 引言

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章 市场情势

  • 市场概览
  • 市场驱动因素
    • 生技药品和细胞疗法生产的快速扩张需要无菌过滤
    • 基因组学和蛋白​​质组学工作流程的小型化推动了对基于微孔盘的过滤的需求。
    • CRO 和 CDMO 的成长推动了成本效益型过滤组件的发展
    • 生技产业的研发成本不断上升
    • 实验室过滤技术进步。
    • 永续性过滤
  • 市场限制
    • 重复使用杀菌级过滤器以及特殊过滤器的高成本
    • 奈米多孔膜的变异性限制了生技药品检测的重现性。
    • 医药采购商整合加剧滤芯供应商利润压力
    • PFAS修復成本
  • 波特五力分析
    • 新进入者的威胁
    • 买方的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争对手之间的竞争

第五章 市场规模及成长预测（美元）

  • 依技术
    • 微过滤
    • 超过滤
    • 逆渗透
    • 真空过滤
    • 奈米过滤
  • 按产品
    • 过滤材料
      • 薄膜过滤器
      • 滤纸
      • 过滤微孔盘
      • 无针头过滤器
      • 针头过滤器
      • 囊式过滤器
    • 过滤组件
      • 微过滤组件
      • 超过滤装置
      • 真空过滤组件
      • 逆渗透组件
      • 奈米过滤组件
    • 过滤配件
  • 最终用户
    • 製药和生物技术公司
    • 学术研究机构
    • 合约研究组织 (CRO) 和合约研发生产力组织 (CDMO)
    • 医院和诊断实验室
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • GCC
      • 南非
      • 其他中东和非洲地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美

第六章 竞争情势

  • 市场集中度
  • 策略趋势
  • 市占率分析
  • 公司简介
    • 3M
    • Merck KGaA
    • Danaher Corporation
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • GVS SpA
    • Cole-Parmer Instrument LLC
    • Agilent Technologies Inc.
    • Ahlstrom-Munksjo
    • Abcam PLC
    • Purolite Corp.
    • Repligen Corp.
    • Parker Hannifin
    • Sterlitech Corp.
    • Advantec MFS Inc.
    • GE Healthcare
    • Cobetter Filtration Equipment Co.
    • Graver Technologies LLC
    • Meissner Filtration Products
    • Porvair Filtration Group

第七章 市场机会与未来展望

简介目录
Product Code: 62768

The Laboratory Filtration Market size is estimated at USD 4.70 billion in 2025, and is expected to reach USD 6.91 billion by 2030, at a CAGR of 8.02% during the forecast period (2025-2030).

Laboratory Filtration - Market - IMG1

Rising biopharmaceutical production volumes, rapid adoption of single-use process technologies, and escalating purity requirements in advanced research workflows underpin this expansion. Precision-grade microfiltration continues to anchor routine clarification steps, while breakthrough nanofiltration platforms are gaining traction for molecular-level separations in cell and gene therapy pipelines. Heightened outsourcing to contract research and development manufacturing organizations (CRDMOs) is widening access to flexible filtration assemblies, and sustainability initiatives are accelerating the shift toward PFAS-free membranes. Competitive differentiation now revolves around virus-retentive performance, automation readiness, and digital compatibility, encouraging a steady wave of product upgrades and platform integrations across the laboratory filtration market.

Global Laboratory Filtration Market Trends and Insights

Rapid expansion of biologics manufacturing

Biologics pipelines are scaling quickly in monoclonal antibodies, recombinant proteins, vaccines, and cell-based therapies. Downstream purification now demands sterile, virus-retentive filters that handle higher titers without compromising biomolecule integrity. Asahi Kasei Medical's Planova FG1 filter, released in October 2024, demonstrates a seven-fold increase in volumetric throughput for antibody processing while preserving virus clearance performance. Strong demand for single-use bag-integrated cartridges further propels the laboratory filtration market as manufacturers build flexible plants capable of rapid product changeovers.

Miniaturization of genomics & proteomics workflows

High-throughput sequencing and multiplexed proteomics have condensed sample volumes from milliliters to microliters. Filtration devices compatible with 96- and 384-well plates are now standard in next-generation sequencing (NGS) library preparation and biomarker validation assays. Cytiva's Whatman Mini-UniPrep G2 syringeless filters combine protein precipitation, particulate removal, and autosampler vial integration in one step, cutting plastic use and hands-on time while meeting the precision needs of ultrahigh-performance liquid chromatography (UHPLC). Automation-friendly formats position the laboratory filtration market for sustained uptake in digital, walk-away genomics platforms.

Reuse of sterilizing-grade filters & high cost

Laboratories under fiscal pressure often attempt to recycle expensive sterilizing-grade membranes, reducing consumable spend by up to 50% but amplifying contamination and validation risks. The burden is acute in small academic labs and resource-limited geographies, where filter integrity testing infrastructure may be lacking.

Other drivers and restraints analyzed in the detailed report include:

  1. Growth of CROs & CDMOs
  2. Rise in R&D spending by biotechnology industries
  3. Variability in nanoporous membranes

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

The laboratory filtration market size for microfiltration amounted to 40.2% of global revenue in 2024, underscoring its ubiquity in microorganism removal and sample clarification tasks. Nanofiltration, however, is on pace to compound at 9.6% annually to 2030 as laboratories adopt molecular-level cutoffs for virus clearance, salt-selective separations, and therapeutic-grade buffer production. The FilmTec LiNE-XD element from DuPont illustrates this shift, achieving high lithium passage while excluding multivalent ions critical to battery-material quality control.

Ultrafiltration and reverse osmosis remain cornerstones for protein concentration and ultrapure water generation respectively. Hybrid membranes combining graphene oxide channels with polymer backbones point toward the next wave of cross-disciplinary breakthroughs. Such innovations blur legacy boundaries, compelling vendors to articulate performance metrics in terms relevant to biotherapeutics, semiconductor rinsing, and environmental testing alike.

The Laboratory Filtration Market Report is Segmented by Technology (Microfiltration, Ultrafiltration, Reverse Osmosis, and More), Product (Filtration Media, Filtration Assemblies, and Filtration Accessories), End User (Pharmaceutical and Biotechnology Companies, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

North America generated the largest share 36.4% of the laboratory filtration market in 2024 owing to its advanced pharmaceutical R&D, dense biotech clusters, and strict quality regulations. Boston's Kendall Square, the San Francisco Bay Area, and San Diego collectively orchestrate high-throughput biologics discovery pipelines, securing recurring orders for sterilizing-grade media, depth filters, and disposable capsules. Canada's biologics capacity expansion programs and Mexico's cost-competitive fill-finish facilities further elevate regional unit volumes.

Asia-Pacific is the most dynamic arena, advancing at a 10.7% CAGR through 2030. China's provincial life-science parks are outfitting greenfield plants with single-use filtration trains to support mRNA vaccines and gene-edited cell therapies. Singapore's Biomedical Sciences Initiative and South Korea's pharmaceutical stimulus packages intensify local demand for automation-ready filtration units, while Japan sustains premium segments with ultra-high precision membrane grades. India's generics producers reinforce bulk-drug filtration throughput, emphasizing cost-efficient media that maintain compliance with PIC/S harmonization guidelines.

Europe maintains significant weight in the global laboratory filtration market. Germany's engineering heritage fosters steady adoption of advanced membrane modules, and the United Kingdom's cell therapy manufacturing ecosystem drives specialty filter designs optimized for viral vector purification. France, Switzerland, and the Nordic countries extend the region's footprint with strong analytical testing sectors. In South America, Brazil anchors investment in vaccine fill-finish lines, whereas the Middle East & Africa are witnessing incremental gains tied to national immunization and water-quality programs.

  1. 3M
  2. Merck
  3. Danaher
  4. Sartorius
  5. Thermo Fisher Scientific
  6. GVS SpA
  7. Cole-Parmer Instrument LLC
  8. Agilent Technologies
  9. Ahlstrom-Munksjo
  10. Abcam
  11. Purolite Corp.
  12. Repligen Corp.
  13. Parker Hannifin
  14. Sterlitech Corp.
  15. Advantec MFS
  16. GE Healthcare
  17. Cobetter Filtration Equipment Co.
  18. Graver Technologies LLC
  19. Meissner Filtration Products
  20. Porvair Filtration Group

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Expansion of Biologics & Cell-Therapy Manufacturing Requiring Sterile Filtration
    • 4.2.2 Miniaturization of Genomics & Proteomics Workflows Fueling Microplate-Based Filtration Demand
    • 4.2.3 Growth of CROs & CDMOs Boosting Cost-Effective Filtration Assemblies
    • 4.2.4 Rise in Research and Development Spending by the Biotechnology Industries
    • 4.2.5 Technological Advancements in Laboratory Filtration
    • 4.2.6 Sustainability-driven Filtration Innovation
  • 4.3 Market Restraints
    • 4.3.1 Reuse of Sterilizing-grade Filters and High Cost of Specialized Filters
    • 4.3.2 Variability in Nanoporous Membranes Limiting Reproducibility for Biologics Assays
    • 4.3.3 Consolidation of Pharma Buyers Increasing Margin Pressure on Filter Vendors
    • 4.3.4 PFAS-Driven Reformulation Costs
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitutes
    • 4.4.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value in USD)

  • 5.1 By Technology
    • 5.1.1 Microfiltration
    • 5.1.2 Ultrafiltration
    • 5.1.3 Reverse Osmosis
    • 5.1.4 Vacuum Filtration
    • 5.1.5 Nanofiltration
  • 5.2 By Product
    • 5.2.1 Filtration Media
      • 5.2.1.1 Membrane Filters
      • 5.2.1.2 Filter Papers
      • 5.2.1.3 Filtration Microplates
      • 5.2.1.4 Syringeless Filters
      • 5.2.1.5 Syringe Filters
      • 5.2.1.6 Capsule Filters
    • 5.2.2 Filtration Assemblies
      • 5.2.2.1 Microfiltration Assemblies
      • 5.2.2.2 Ultrafiltration Assemblies
      • 5.2.2.3 Vacuum Filtration Assemblies
      • 5.2.2.4 Reverse Osmosis Assemblies
      • 5.2.2.5 Nanofiltration Assemblies
    • 5.2.3 Filtration Accessories
  • 5.3 By End User
    • 5.3.1 Pharmaceutical and Biotechnology Companies
    • 5.3.2 Academic and Research Institutes
    • 5.3.3 CRO and CDMO
    • 5.3.4 Hospital and Diagnostic Laboratories
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.4.1 3M
    • 6.4.2 Merck KGaA
    • 6.4.3 Danaher Corporation
    • 6.4.4 Sartorius AG
    • 6.4.5 Thermo Fisher Scientific Inc.
    • 6.4.6 GVS SpA
    • 6.4.7 Cole-Parmer Instrument LLC
    • 6.4.8 Agilent Technologies Inc.
    • 6.4.9 Ahlstrom-Munksjo
    • 6.4.10 Abcam PLC
    • 6.4.11 Purolite Corp.
    • 6.4.12 Repligen Corp.
    • 6.4.13 Parker Hannifin
    • 6.4.14 Sterlitech Corp.
    • 6.4.15 Advantec MFS Inc.
    • 6.4.16 GE Healthcare
    • 6.4.17 Cobetter Filtration Equipment Co.
    • 6.4.18 Graver Technologies LLC
    • 6.4.19 Meissner Filtration Products
    • 6.4.20 Porvair Filtration Group

7 Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet-Need Assessment